WP2 Objectives:
- Provide evidence of
- Clinical effectiveness
- Cost effectiveness to the patient, healthcare system and society
- Clinical utility
- Study protocol and ethics documentation development, review and approval
- Clinical study set up and site training in France, Germany, Spain, the Netherlands and the United Kingdom
- Recruit and complete 776 patients in the P1vital® PReDicT Test directed treatment and Treatment as Usual arms
- Author and complete the clinical study reports
- Produce and submit study publications
WP2 Lead: Dr Michael Browning and Dr Gerry Dawson
WP2 Partners:
- Cost Effectiveness – Professor Judit Simon at Medical University of Vienna
- Clinical Utility – Professor Richard Morriss at MindTech and Dr Sue Brown at University of Nottingham
- Clinical Study Coordination:
- NHS Primary Care in UK
- France – Professor Philip Gorwood at Hospital Sainte-Anne, Paris Descartes University
- Germany – Professor Jürgen Deckert at Klinikum der Universität Würzburg and Professor Andreas Reif at University Hospital Frankfurt
- Spain – Dr Víctor Pérez Sola at University Hospital Barcelona
- The Netherlands – Dr Dick J. Veltman at VU University Medical Centre Amsterdam, GGZ inGeest